Specific signaling pathways mediated programmed cell death in tumor microenvironment and target therapies

Chengpeng Sun1,2, Jiawei Gui1,2, Yilei Sheng1,2

  • 1The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.1, Minde Road, Donghu District, Nanchang, 330006, Jiangxi, China.

Discover Oncology
|May 16, 2025
PubMed

Insights

Programmed cell death (PCD) mechanisms like apoptosis and necroptosis are vital in cancer. Targeting key signaling pathways offers new therapeutic strategies for improved cancer treatment outcomes.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Programmed cell death (PCD) is integral to tumorigenesis and cancer progression.
  • PCD encompasses diverse, interconnected mechanisms including apoptosis, necroptosis, alkaliptosis, oxeiptosis, and anoikis.

Purpose of the Study:

  • To comprehensively review the multifaceted nature of PCD.
  • To elucidate the regulatory mechanisms of key signaling pathways in PCD and tumor progression.

Main Methods:

  • Description of the generation mechanisms of different PCD components.
  • Focus on the regulatory roles of caspase, RIPK1/RIPK3/MLKL, and mTOR signaling pathways in global PCD.

Main Results:

  • Detailed examination of the interplay between PCD pathways and tumor development.
  • Identification of therapeutic compounds targeting specific signaling axes within these pathways.

Conclusions:

  • Understanding PCD signaling is crucial for developing novel cancer therapies.
  • Targeting PCD pathways presents promising strategies to enhance tumor treatment efficacy and patient outcomes.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.8K